Medical Research News

RSS

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

A new study, released as a preprint on bioRxiv* server, shows that a combination of the biological interferon-α and the small molecule nafamostat are effective against SARS-CoV-2 infection in vitro, as well as in vivo.

18 Jun 2021

Breathonix 60-Second COVID-19 Breath Test Powered by IONICON

Roll-out of PTR-TOF breath test with provisional authorization in Singapore.

From Ionicon Analytik Ges.m.b.H. 18 Jun 2021

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

Underlining the key role of genomic surveillance in keeping tabs on the spread of SARS-CoV-2, a new medRxiv* preprint shows how a new variant called B.1.1.318 rose to dominance in the small island country of Mauritius, in the Indian Ocean.

18 Jun 2021

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

A new study, released as a preprint on the bioRxiv* server, reveals the high neutralizing efficacy of hyperimmune horse serum against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This could prove, if validated, to be a more affordable yet potent therapeutic in reducing the morbidity and mortality caused by this virus.

18 Jun 2021

First insights into human prion disease could help tackle neurodegenerative diseases

Surface features of human prions have been identified for the first time, which may provide key information into treatments of neurodegenerative diseases.

18 Jun 2021

Fighting the good fight –a new protein found in red blood cells linked to limiting cognitive decline

A new study shows that depleting mouse blood of the protein ADORA2B led to faster declines in memory, and increased brain inflammation.

18 Jun 2021

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Convalescent plasma therapy was associated with better survival in blood cancer patients hospitalized with COVID-19, especially in sicker patients. The findings by the COVID-19 and Cancer Consortium (CCC19) are newly published in the peer-reviewed journal JAMA Oncology.

18 Jun 2021

Study highlights need to address the mental health of new fathers

While postpartum depression in new mothers is well recognized and known to increase if the newborn requires intensive care, depression in new fathers has not received much attention.

18 Jun 2021

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Scientists have a general idea of how viruses invade and spread in the body, but the precise mechanisms are actually not well understood, especially when it comes to Ebola virus.

18 Jun 2021

Controlling brain state transitions using a molecule responsive to light

A study led by researchers from IBEC and IDIBAPS achieves, for the first time, the control of brain state transitions using a molecule responsive to light, named PAI.

18 Jun 2021

COVID-19 virus can infect the testes, hamster study shows

Researchers at the University of Texas Medical Branch have observed that SARS-CoV-2, the virus that causes COVID-19, can infect the testes of infected hamsters.

18 Jun 2021

UofSC researcher to examine the effectiveness of Medicaid-covered alcohol use disorder treatment

Christina Andrews, associate professor of health services policy and management at the University of South Carolina's Arnold School of Public Health and an expert on addiction treatment will lead a study funded by the National Institute of Alcohol Abuse and Alcoholism to examine the effectiveness of Medicaid-covered alcohol use disorder treatment.

18 Jun 2021

Previous SARS-CoV-2 infection, vaccines provide protection against gamma variant, study finds

In early January 2021, travelers returning to Tokyo, Japan, from Amazonas, Brazil, were screened for COVID-19 at the airport. A few days later, the National Institute of Infectious Disease of Japan announced that the travelers had returned with a new variant of the SARS-CoV-2 virus.

18 Jun 2021

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

KIYATEC, Inc. announced today the publication of new peer-reviewed data that establishes clinically meaningful prediction of patient-specific responses to standard of care therapy, prior to treatment, in newly diagnosed glioblastoma (GBM) and other high-grade glioma (HGG) patients.

18 Jun 2021

Protein found in mice’s immune system could protect babies from necrotizing enterocolitis

The intestinal disease necrotizing enterocolitis is a leading cause of death among premature infants born in the U.S. and across the globe.

18 Jun 2021

Chan Zuckerberg Initiative announces nearly $28 million for visual proteomics

Today, the Chan Zuckerberg Initiative (CZI) announced nearly $28 million in grants to support technology developments that will allow researchers to see the inner workings of cells at near-atomic resolution through next-generation electron microscopy.

18 Jun 2021

Study examines SARS-CoV-2 replication in cells using super-resolution microscopy

Despite tremendous efforts by the global scientific community to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), by developing more efficient testing protocols, therapies, and vaccines at a rapid pace, relatively little is known about the dynamics of SARS-CoV-2 replication within cells.

18 Jun 2021

Nanodecoys made from human lung spheroid cells can neutralize SARS-CoV-2

Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19.

18 Jun 2021

Study shows mRNA COVID-19 vaccines is safe for male reproduction

The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA, the most widely circulated general medical journal in the world.

18 Jun 2021

Convalescent plasma can improve chances of survival among blood cancer patients with COVID-19

A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus.

18 Jun 2021

Medical Research News

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Breathonix 60-Second COVID-19 Breath Test Powered by IONICON

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

First insights into human prion disease could help tackle neurodegenerative diseases

Fighting the good fight –a new protein found in red blood cells linked to limiting cognitive decline

Convalescent plasma associated with better survival in blood cancer patients with COVID-19

Study highlights need to address the mental health of new fathers

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Controlling brain state transitions using a molecule responsive to light

COVID-19 virus can infect the testes, hamster study shows

UofSC researcher to examine the effectiveness of Medicaid-covered alcohol use disorder treatment

Previous SARS-CoV-2 infection, vaccines provide protection against gamma variant, study finds

KIYATEC’s test results accurately predict treatment response in recurrent high-grade glioma patients

Protein found in mice’s immune system could protect babies from necrotizing enterocolitis

Chan Zuckerberg Initiative announces nearly $28 million for visual proteomics

Study examines SARS-CoV-2 replication in cells using super-resolution microscopy

Nanodecoys made from human lung spheroid cells can neutralize SARS-CoV-2

Study shows mRNA COVID-19 vaccines is safe for male reproduction

Convalescent plasma can improve chances of survival among blood cancer patients with COVID-19

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

Latest News